Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc (NasdaqGS:MGTX) for approximately $130 million on December 21, 2023. As part of consideration $65 million will pay at signing, an additional $50 million anticipated in the first quarter of 2024, with the remaining $15 million in milestone payments expected later in 2024. Evercore Group L.L.C. acted as financial advisor to MeiraGTx Holdings plc (NasdaqGS:MGTX) and Morgan, Lewis & Bockius LLP acted as legal advisor to MeiraGTx Holdings plc (NasdaqGS:MGTX).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.065 USD | +1.30% | +3.16% | -27.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.85% | 326M | |
+9.15% | 106B | |
-1.08% | 104B | |
+5.79% | 23.25B | |
-11.55% | 22.5B | |
-7.01% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- MGTX Stock
- News MeiraGTx Holdings plc
- Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc for approximately $130 million.